Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
-
Ann Thorac Cardiovasc Surg · Feb 2002
Comparative Study Clinical TrialCytokine responses to myocardial revascularization on cardiopulmonary bypass: intermittent crossclamping versus blood cardioplegic arrest.
The inflammatory responses to the different myocardial protection approaches have not been thoroughly investigated. We sought to study the cytokine responses to cardiopulmonary bypass (CPB) using the intermittent aortic crossclamping with ventricular fibrillation (IAC) versus blood cardioplegic arrest (BC) techniques. ⋯ Despite the duration of ischemia and CPB being shorter, intermittent aortic crossclamping is associated with an enhanced pro-inflammatory but a reduced anti-inflammatory response compared to the cardioplegic arrest technique. Its clinical relevance needs to be further defined.
-
Ann Thorac Cardiovasc Surg · Feb 2002
The long-term follow-up results of elective surgical treatment for abdominal aortic aneurysms.
This study was aimed at evaluating early and long-term follow-up results of surgical reconstruction of infrarenal abdominal aortic aneurysms (AAA). A consecutive series of 392 patients who underwent elective abdominal aortic repair from 1974 to 2000 was reviewed retrospectively. The mean age was 69.8 years (range 34-90), with 329 males and 63 females. ⋯ There were statistically significant differences between the ischemic heart disease and the non-ischemic heart disease, the aortoiliac occlusive disease and the non-aortoiliac occlusive disease in long-term survival rates respectively. These findings demonstrate that AAA patients associated with ischemic heart disease or aortoiliac occlusive disease are at a higher risk than those with AAA alone. Therefore, AAA patients with aortoiliac occlusive disease and or ischemic heart disease should be managed more intensively before, during and after the operation.
-
Ann Thorac Cardiovasc Surg · Feb 2002
Preclinical evaluation of a new hollow fiber silicone membrane oxygenator for pediatric cardiopulmonary bypass: ex-vivo study.
Based on the results of many experimental models, a hollow fiber silicone membrane oxygenator applicable for long-term extracorporeal membrane oxygenation (ECMO) was developed. For further high performance and antithrombogenicity, this preclinical model was modified, and a new improved oxygenator was successfully developed. In addition to ECMO application, the superior biocompatibility of silicone must be advantageous for pediatric cardiopulmonary bypass (CPB). ⋯ For six hours, the O2 and CO2 gas transfer rates were maintained around 90 and 80 ml/min at a blood flow rate of 2 L/min and V/Q=3, respectively. The plasma free hemoglobin was maintained around 5 mg/dl. These data suggest that this newly improved oxygenator has superior efficiency, less blood trauma, and may be suitable for not only long-term ECMO but also pediatric CPB usage.